Table 2.
Markers significantly associated with OS benefit under immune checkpoint inhibitors. HR = Hazard ratio; 95% CI = 95% confidence interval.
Markers associated with OS benefit | ||||||||
---|---|---|---|---|---|---|---|---|
Compartment | Marker | Cut-off point |
Log-rank HR (95% CI) |
P | Univariable HR (95% CI) |
P | Multivariable HR (95% CI) |
P |
CD68 | ERK1/2 | Median | 0.39 (0.15–0.98) | .043 | 0.36 (0.13–1.01) | .042 | 0.24 (0.07–0.77) | .012 |
ERK1/2 | Top tertile | .32 (.12–.82) | 0.052 | .31 (.09–1.08) | 0.039 | .14 (.03–.74) | 0.0079 | |
HLA-DR | Median | .26 (.10–.67) | 0.0048 | .22 (.07–.70) | 0.0045 | .09 (.01–.55) | 0.0035 | |
HLA-DR | Top tertile | .30 (.12–.76) | 0.039 | .29 (.08–1.01) | 0.028 | .22 (.05–1.02) | 0.037 | |
HLA-DR | Top quartile | .12 (.04–.30) | 0.010 | .12 (.02–.89) | 0.010 | .11 (.01–1.18) | 0.019 | |
CD45 | PD-1 | Median | 2.95 (1.10–7.94) | .033 | 3.01 (1.04–8.73) | .034 | 1.93 (0.49–7.54) | .34 |
LAG3 | Median | 3.00 (1.11–8.08) | 0.032 | 3.02 (1.05–8.73) | 0.032 | 3.02 (.65–13.94) | 0.14 | |
MART1 | Median | 2.75 (1.03–7.38) | 0.047 | 2.82 (.97–8.19) | 0.047 | 1.77 (.50–6.28) | 0.37 | |
OX40L | Top tertile | 3.07 (.98–9.59) | 0.016 | 3.28 1.18–9.11) | 0.025 | 5.83 (1.71–19.84) | 0.0046 | |
BCL6 | Top quartile | 2.61 (.74–9.16) | 0.049 | 2.75 (.96–7.85) | 0.072 | 3.20 (.88–11.7) | 0.087 | |
CD45+CD68 | BIM | Top quartile | 2.70 (0.96–7.61) | .020 | 1.99 (0.81–4.87) | .14 | 1.18 (0.40–3.53) | .8 |
Bold values represent the Values equal or below 0.05.